XTL BIOPHARMACEUTICALS LTD. Finance Income
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Finance Income of $1.13 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Income Statement › Other Income
ifrs-full:FinanceIncome · last filed 2025-04-30
| Period end | Finance Income 12 month | Finance Income 12 month as first filed |
|---|---|---|
| 2024-12-31 | $1.13M 20-F · filed 2025-04-30 | |
| 2023-12-31 | $41.00K 20-F · filed 2025-04-30 | |
| 2022-12-31 | $1.09M 20-F · filed 2025-04-30 | |
| 2021-12-31 | $1.49M 20-F · filed 2023-03-22 | |
| 2020-12-31 | $183.00K 20-F · filed 2023-03-22 | |
| 2019-12-31 | $682.00K 20-F · filed 2022-03-30 | $98.00K 20-F · filed 2020-03-12 |
| 2018-12-31 | $3.81M 20-F · filed 2021-03-15 | |
| 2017-12-31 | $802.00K 20-F · filed 2020-03-12 | |
| 2016-12-31 | $23.00K 20-F · filed 2019-03-11 | |
| 2015-12-31 | $4.00K 20-F · filed 2018-03-15 |